PPMX-2017

N/A

Report date: 2025/09/29 14:28:16

Base Information

Drug NamePPMX-2017

Drug Alias NamePPMX-2017

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murine

Mechanisms of ActionCadherin 3 inhibitorsAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsAdhesion Molecule With Ig Like Domain 2 antagonists

TargetsCadherin 3Adhesion Molecule With Ig Like Domain 2

Therapy Area/IndicationsLung Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPerseus Proteomics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPerseus Proteomics Inc

Active IndicationsN/A

Inactive IndicationsLung Neoplasms

Other Information

ATC CodeN/A